Canadian tech firm Zentek plans a Normal Course Issuer Bid to buy up to 5% of its shares over a year.
Zentek Ltd., a Canadian IP tech firm, plans a Normal Course Issuer Bid (NCIB) to buy up to 5,084,319 common shares, approx. 5% of its issued & outstanding shares, over a year. The purchases will be made on the TSX Venture Exchange, with a max of 2% per 30-day period. Zentek's board believes its stock price might not fully reflect its business value. Integral Wealth Securities Limited is appointed as the broker for the NCIB, which may run until August 15, 2025. Zentek's ZenGUARD tech platform shows 99% anti-microbial activity and increased viral filtration efficiency for surgical masks, potentially enhancing HVAC systems.
August 14, 2024
6 Articles